2017 annual financial data
Atossa Therapeutics 2017 Operating margin
Atossa Therapeutics 2017 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -7,187,456 USD and net income was -8,122,581 USD.
Operating cash flow was -6,593,950 USD.
Get free Atossa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -7,187,456 USD
- Net income
- -8,122,581 USD
- Operating cash flow
- -6,593,950 USD